Klaas Kok

8.9k total citations
128 papers, 4.4k citations indexed

About

Klaas Kok is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Klaas Kok has authored 128 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 48 papers in Cancer Research and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Klaas Kok's work include Genomic variations and chromosomal abnormalities (27 papers), Cancer Genomics and Diagnostics (26 papers) and RNA modifications and cancer (24 papers). Klaas Kok is often cited by papers focused on Genomic variations and chromosomal abnormalities (27 papers), Cancer Genomics and Diagnostics (26 papers) and RNA modifications and cancer (24 papers). Klaas Kok collaborates with scholars based in Netherlands, United States and Germany. Klaas Kok's co-authors include Anke van den Berg, C.H.C.M. Buys, Susan L. Naylor, Charles H.C.M. Buys, Gerben Duns, B. Carritt, Robert M.W. Hofstra, Sibrand Poppema, Anneke Y. van der Veen and Harry J.M. Groen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Klaas Kok

123 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaas Kok Netherlands 38 2.9k 1.3k 1.0k 977 766 128 4.4k
David Gisselsson Sweden 40 2.7k 0.9× 1.4k 1.0× 1.1k 1.1× 966 1.0× 1.0k 1.4× 151 5.0k
David W. Goodrich United States 34 3.1k 1.1× 788 0.6× 2.3k 2.2× 525 0.5× 1.1k 1.5× 97 5.0k
Dirce Maria Carraro Brazil 33 1.8k 0.6× 1.0k 0.8× 929 0.9× 585 0.6× 435 0.6× 188 3.4k
David Wotton United States 33 5.5k 1.9× 681 0.5× 1.2k 1.1× 907 0.9× 325 0.4× 72 6.7k
B D Nelkin United States 10 5.4k 1.9× 989 0.7× 1.2k 1.2× 792 0.8× 473 0.6× 13 6.3k
Svetlana Pack United States 47 3.1k 1.1× 1.1k 0.8× 1.5k 1.5× 1.1k 1.1× 1.4k 1.8× 130 6.5k
A. Bassim Hassan United Kingdom 28 2.8k 1.0× 570 0.4× 828 0.8× 548 0.6× 1.0k 1.4× 64 4.5k
Valérie Combaret France 34 2.3k 0.8× 1.4k 1.0× 1.2k 1.2× 426 0.4× 417 0.5× 88 4.1k
Bernard E. Weissman United States 45 5.6k 1.9× 852 0.6× 1.5k 1.5× 926 0.9× 580 0.8× 122 7.1k
Matthew J. Smalley United Kingdom 39 3.5k 1.2× 1.1k 0.8× 2.9k 2.8× 829 0.8× 687 0.9× 79 5.5k

Countries citing papers authored by Klaas Kok

Since Specialization
Citations

This map shows the geographic impact of Klaas Kok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaas Kok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaas Kok more than expected).

Fields of papers citing papers by Klaas Kok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaas Kok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaas Kok. The network helps show where Klaas Kok may publish in the future.

Co-authorship network of co-authors of Klaas Kok

This figure shows the co-authorship network connecting the top 25 collaborators of Klaas Kok. A scholar is included among the top collaborators of Klaas Kok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaas Kok. Klaas Kok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jun, Cuiyun Zhang, Siyu Wang, et al.. (2024). Profiling of driver mutations in lung adenocarcinoma patients identifies rare compound EGFR mutations sensitive to second-generation EGFR-TKIs. SHILAP Revista de lepidopterología. 3(1).
2.
Llobet, Sergi Guerrero, Arkajyoti Bhattacharya, Marieke Everts, et al.. (2022). An mRNA expression-based signature for oncogene-induced replication-stress. Oncogene. 41(8). 1216–1224. 26 indexed citations
3.
Plaça, Jéssica Rodrigues, Erlin A. Haacke, Martijn Terpstra, et al.. (2022). Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren’s Syndrome. Cancers. 14(4). 1010–1010. 9 indexed citations
4.
Westers, Helga, Manon van Engeland, Martijn Terpstra, et al.. (2022). Evaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma. Scientific Reports. 12(1). 6478–6478. 4 indexed citations
5.
Rybczynska, Anna A., Martijn Terpstra, Ali Saber, et al.. (2020). An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients. Cancers. 12(10). 2843–2843. 9 indexed citations
6.
Feen, Diederik E. van der, Guido P. L. Bossers, Quint A. J. Hagdorn, et al.. (2020). Cellular senescence impairs the reversibility of pulmonary arterial hypertension. Science Translational Medicine. 12(554). 85 indexed citations
7.
Kats‐Ugurlu, Gürsah, Rolf H. Sijmons, Martijn Terpstra, et al.. (2019). Comprehensive Profiling of Primary and Metastatic ccRCC Reveals a High Homology of the Metastases to a Subregion of the Primary Tumour. Cancers. 11(6). 812–812. 14 indexed citations
8.
Nagy, Roland, Aafke P.A. van Montfoort, Uwe J.F. Tietge, et al.. (2018). Differential miRNA Expression Profiles in Cumulus and Mural Granulosa Cells from Human Pre-ovulatory Follicles. MicroRNA. 8(1). 61–67. 29 indexed citations
9.
Dzikiewicz‐Krawczyk, Agnieszka, Arjan Diepstra, Bea Rutgers, et al.. (2018). Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells. American Journal Of Pathology. 188(5). 1289–1299. 6 indexed citations
10.
Kats‐Ugurlu, Gürsah, et al.. (2017). DNA and RNA analysis of intratumour heterogeneity in metastatic clear cell renal cell carcinoma. Annals of Oncology. 28. vii31–vii31. 2 indexed citations
11.
Saber, Ali, Anthonie J. van der Wekken, Klaas Kok, et al.. (2016). Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing. PLoS ONE. 11(4). e0153065–e0153065. 13 indexed citations
12.
Falahi, Fahimeh, Christian Huisman, Hinke G. Kazemier, et al.. (2013). Towards Sustained Silencing of HER2/neu in Cancer By Epigenetic Editing. Molecular Cancer Research. 11(9). 1029–1039. 60 indexed citations
13.
Röser, Kerstin, Thomas Löning, Bauke Ylstra, et al.. (2008). Copy number gain at 8q12.1‐q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas. Genes Chromosomes and Cancer. 48(2). 202–212. 13 indexed citations
14.
Gibcus, Johan H., Lorian Menkema, Mirjam F. Mastik, et al.. (2007). Amplicon Mapping and Expression Profiling Identify the Fas-Associated Death Domain Gene as a New Driver in the 11q13.3 Amplicon in Laryngeal/Pharyngeal Cancer. Clinical Cancer Research. 13(21). 6257–6266. 74 indexed citations
15.
Booman, Marije, Annuska M. Glas, Sietske A. Riemersma, et al.. (2006). Mechanisms and Effects of Loss of Human Leukocyte Antigen Class II Expression in Immune-Privileged Site-Associated B-Cell Lymphoma. Clinical Cancer Research. 12(9). 2698–2705. 53 indexed citations
16.
Kok, Klaas, Joost Kluiver, Eva van den Berg, et al.. (2006). BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma–derived cell line DEV. Human Pathology. 37(6). 675–683. 24 indexed citations
17.
Kok, Klaas, Trijnie Dijkhuizen, Pieter van der Vlies, et al.. (2005). Application of a comprehensive subtelomere array in clinical diagnosis of mental retardation. European Journal of Medical Genetics. 48(3). 250–262. 26 indexed citations
18.
Carvalho, Beatriz, Raquel Seruca, Fátima Carneiro, Charles H.C.M. Buys, & Klaas Kok. (1999). Substantial reduction of the gastric carcinoma critical region at 6q16.3-q23.1. Genes Chromosomes and Cancer. 26(1). 29–34. 19 indexed citations
19.
Hout, Annemarie H. van der, et al.. (1989). Localization of amplified c-myc and n-myc in small cell lung cancer cell lines. Cancer Genetics and Cytogenetics. 38(1). 1–8. 13 indexed citations
20.
Hout, Annemarie H. van der, Klaas Kok, Anke van den Berg, et al.. (1988). Direct molecular analysis of a deletion of 3p in tumors from patients with sporadic renal cell carcinoma. Cancer Genetics and Cytogenetics. 32(2). 281–285. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026